Team |
Bikash Shakya, PhD
Bikash Shakya, PhD

Bikash Shakya, PhD

Scientist II

Technology Development

Bikash is focused on developing and optimizing novel therapeutic gene editing technologies using RNA-guided nucleases and base editors.

Prior to joining Life Edit Therapeutics, he worked at Asklepios BioPharmaceutical, Inc. (AskBio, subsidiary of Bayer AG) and Taysha Gene Therapies, where he led cell line engineering programs for CRISPR-mediated development of in-vitro disease models for rare diseases. He also investigated cellular and molecular mechanisms for optimal recombinant AAV vector production.

Bikash received his PhD in Microbiology from Purdue University where he studied host pathogen interaction in parasite infected red blood cells in malaria. He continued his studies in the host pathogen interaction as a Postdoctoral Research Fellow at Stanford University, before transitioning to industry.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.